SCHEDULE 13G

Statement of Beneficial Ownership

Protalix BioTherapeutics, Inc. Filed 2026-07-29 Acc 0002012383-26-002863

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-10-15 SCHEDULE 13G Statement of Beneficial Ownership
2026-07-29 SCHEDULE 13G Statement of Beneficial Ownership
2026-03-04 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

External

SEC EDGAR (opens in new tab)